BioSpace News Archive

Drug Development

Curis Announces FDA Partial Clinical Hold for TakeAim Leukemia Study of Emavusertib (CA-4948)

Curis, Inc. announced that the U.S. Food and Drug Administration has placed a partial clinical hold on the Company’s TakeAim Leukemia Phase 1/2a study.

April 4, 2022
·
8 min read
Biotech Bay

Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics

Microba Life Sciences, a precision microbiome science company, and Ginkgo Bioworks, the leading horizontal platform for cell programming, announced a partnership to identify single-strain, live bacteria product candidates against autoimmune diseases.

April 4, 2022
·
6 min read
Business

OcuTerra Appoints Majid Anderesi, MD, as Vice President of Clinical and Medical Affairs

OcuTerra Therapeutics, Inc. announced the appointment of eye care industry veteran Majid Anderesi, MD, as Vice President of Clinical and Medical Affairs.

April 4, 2022
·
3 min read
Spectrum Pharmaceuticals Announces Poster Presentation at the Upcoming AACR Annual Meeting

Spectrum Pharmaceuticals today announced abstract acceptance with a poster presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting, to be held in New Orleans from April 8-13, 2022.

April 4, 2022
·
3 min read
Apyx Medical Corporation Announces FDA 510(k) Submission with Clinical Study Support for the Use of the Renuvion® APR Handpiece for Aesthetic Procedures to Improve Appearance of Lax Skin

Apyx Medical Corporation Announces FDA 510(k) Submission with Clinical Study Support for the Use of the Renuvion ® APR Handpiece for Aesthetic Procedures to Improve Appearance of Lax Skin.

April 4, 2022
·
5 min read
Genetown

Akili to Present at Chardan’s Prescription Digital Therapeutics Half-Day Summit

Akili Interactive today announced that management will present at Chardan’s Prescription Digital Therapeutics Half-Day Summit on Monday, April 11, 2022 at 2:00 p.m. E.T.

April 4, 2022
·
6 min read
FDA

Elite Pharmaceuticals and Praxgen Pharmaceuticals Receive FDA Approval for Generic Doxycycline

Elite Pharmaceuticals, Inc. today announced that together with Elite’s co-development partner, Praxgen Pharmaceuticals LLC received approval from the US Food and Drug Administration (FDA) for doxycycline hyclate 100 mg tablets.

April 4, 2022
·
2 min read
ADC Therapeutics Receives Permanent J-Code for ZYNLONTA® (J9359) from U.S. Centers for Medicare & Medicaid Services

ADC Therapeutics SA announced today that a permanent J-code, J9359, has been issued for ZYNLONTA® by the U.S. Centers for Medicare & Medicaid Services (CMS) effective as of April 1, 2022.

April 4, 2022
·
4 min read
Bruker Expands dia-PASEF® on the timsTOF 4D Proteomics and Epiproteomics Platform to Identify up to 13,000 Protein Groups with 1% FDR

Bruker Expands dia-PASEF ® on the timsTOF 4D Proteomics and Epiproteomics Platform to Identify up to 13,000 Protein Groups with 1% FDR.

April 4, 2022
·
6 min read
Business

Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors

Apollo Endosurgery, Inc. today announced the appointment of Jeannette Bankes to its Board of Directors, bringing the number of board members to eight.

April 4, 2022
·
5 min read